A search on Google using the term “stem cell blogs” quickly produces a host of sites offering treatments for everything from ankle, hip and knee problems, to Parkinson’s disease and asthma. Amazingly the therapies for those very different conditions all use the same kind of cells produced in the same way. It’s like magic. Sadly, … Continue reading Tipping our hat to the good guys (& gals)
U.C. San Diego Scientist Larry Goldstein Joins Stem Cell Agency’s Board
Larry Goldstein, PhD. Larry Goldstein PhD, has many titles, one of which sums up his career perfectly, “Distinguished Professor”. Dr. Goldstein has distinguished himself on many fronts, making him an ideal addition to the governing Board of the California Institute for Regenerative Medicine (CIRM). Dr. Goldstein – everyone calls him Larry - is a Cell … Continue reading U.C. San Diego Scientist Larry Goldstein Joins Stem Cell Agency’s Board
Scientists use stem cells to create Neanderthal-like “mini-brain”
Alysson R. Muotri, Ph.D. The evolution of modern day humans has always been a topic that has been shrouded in mystery. Some of what is known is that Neanderthals, an archaic human species that lived on this planet up until about 11,700 years ago, interbred with our species (Homo sapiens) at some point in time. … Continue reading Scientists use stem cells to create Neanderthal-like “mini-brain”
UCSF Nursing Professor Joins CIRM Board
Elena Flowers, PhD, RN, newest member of the CIRM Board: Photo courtesy UCSF Elena Flowers, PhD, RN, an associate professor of physiological nursing at the University of California, San Francisco (UCSF) is joining the Board of the California Institute for Regenerative Medicine (CIRM), the state’s Stem Cell Agency. Dr. Flowers was appointed to the Board … Continue reading UCSF Nursing Professor Joins CIRM Board
Biotechnology companies join forces in developing treatment for X-SCID
Jasper Therapeutics, Inc., a biotechnology company focused on blood stem cell therapies, and Graphite Bio, Inc., a biotechnology company focused on gene editing therapies to treat or cure serious diseases, announced a research and clinical collaboration for a treatment for X-SCID. X-SCID, which stands for X-linked severe combined immunodeficiency, is a genetic disorder that interferes … Continue reading Biotechnology companies join forces in developing treatment for X-SCID
De-stressing stem cells and the Bonnie & Clyde of stem cells
Dr. John Cashman The cells in our body are constantly signalling with each other, it's a critical process by which cells communicate not just with other cells but also with elements within themselves. One of the most important signalling pathways is called Wnt. This plays a key role in early embryonic and later development. But … Continue reading De-stressing stem cells and the Bonnie & Clyde of stem cells
Surviving with Joy
Dr. Tippi MacKenzie (left) of UCSF Benioff Children’s Hospital San Francisco, visits with newborn Elianna and parents Nichelle Obar and Chris Constantino. Photo by Noah Berger Alpha thalassemia major is, by any stretch of the imagination, a dreadful, heart breaker of a disease. It's caused by four missing or mutated genes and it almost always … Continue reading Surviving with Joy
A retrospective look at CIRM and gratitude for continued support
Maria T. Millan, M.D. President & CEO, CIRM This whole month we have highlighted CIRM and have taken a look back at what has been accomplished since the organization was created in 2004. We end our month of CIRM with a letter from our President & CEO Maria T. Millan, M.D. As we move onward … Continue reading A retrospective look at CIRM and gratitude for continued support
Everything you wanted to know about COVID vaccines but never got a chance to ask
All this month we are using our blog and social media to highlight a new chapter in CIRM’s life, thanks to the voters approving Proposition 14. We are looking back at what we have done since we were created in 2004, and also looking forward to the future. Today we feature a rare treat, an … Continue reading Everything you wanted to know about COVID vaccines but never got a chance to ask
DNA therapeutic treats blood cancer in mice and begins human clinical trial
The left image represents a microscopic view of the bone marrow of a myeloma-bearing mouse treated with control, and the right image represents the same for a myeloma-bearing mouse treated with ION251, an experimental therapeutic. The red dots represent the IRF4 protein within human myeloma cells, which are much sparser after ION251 treatment. Image credit: … Continue reading DNA therapeutic treats blood cancer in mice and begins human clinical trial
The Stem Cellar 